Oncotelic Therapeutics (OTLC) awards CFO 1,500 performance-based RSUs
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Shah Amit B. reported acquisition or exercise transactions in this Form 4 filing.
Oncotelic Therapeutics CFO Amit B. Shah received a grant of 1,500 restricted stock units (RSUs) on July 10, 2026. Each RSU will settle into one share of Series A Convertible Preferred Stock, which is itself convertible into common stock, if performance and time-based vesting conditions tied to a national-exchange uplisting are satisfied.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Shah Amit B.
Role
CFO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted stock Units | 1,500 | $0.00 | -- |
Holdings After Transaction:
Restricted stock Units — 1,500 shares (Direct)
Footnotes (1)
- On July 10, 2026, the reporting person was granted 1,500 restricted stock units ("RSUs"), subject to performance and time-based vesting. On vesting each RSU will immediately be settled by delivery of, and each RSU represents the contingent right to receive, one share of the issuer's Series A Convertible Preferred Stock, par value $0.01. Each share of Series A Convertible Preferred Stock, in turn, is convertible into 1,000 shares of the issuer's common stock, par value $0.01 per share. The RSU's will vest upon (a) achievement of an uplisting of the issuer's common stock to a national securities exchange on or before June 30, 2027 (or such later date as the Board of Directors may approve), subject to the reporting person's continued service for a period of six months following the uplisting.
Key Figures
RSUs granted: 1,500 units
Transaction price per RSU: $0.0000
RSUs outstanding after grant: 1,500 units
+3 more
6 metrics
RSUs granted
1,500 units
Grant to CFO Amit B. Shah on July 10, 2026
Transaction price per RSU
$0.0000
Compensation award with no cash paid per unit
RSUs outstanding after grant
1,500 units
Direct RSU holdings of Amit B. Shah following the award
Conversion ratio
1 Series A Preferred share = 1,000 common shares
Each Series A Convertible Preferred share is convertible into common stock
Uplisting deadline for vesting
June 30, 2027
RSUs vest if an uplisting to a national securities exchange occurs by this date or later if approved
Service requirement post-uplisting
6 months
Continued service period required after uplisting for RSUs to vest
Key Terms
Restricted stock units, Series A Convertible Preferred Stock, uplisting, national securities exchange, +1 more
5 terms
Restricted stock units financial
"was granted 1,500 restricted stock units ("RSUs"), subject to performance"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Series A Convertible Preferred Stock financial
"one share of the issuer's Series A Convertible Preferred Stock, par value $0.01"
Series A convertible preferred stock is a class of shares sold in an early funding round that gives investors a mix of protection and upside: it pays a priority claim over common shares if the company is sold or closes, but can be converted into ordinary shares to share in future growth. Think of it like a hybrid between a safer stake and a ticket to ownership; it matters to investors because it affects who controls the company, how future gains are split, and how much their investment is protected from downside.
uplisting financial
"upon (a) achievement of an uplisting of the issuer's common stock"
Uplisting occurs when a company's stock moves from a less regulated, smaller exchange to a more established and widely recognized one. This transition can make the stock more accessible and attractive to a broader range of investors, potentially increasing its value and trading volume. For investors, uplisting often signals growth and stability, which can influence confidence and trading decisions.
national securities exchange regulatory
"uplisting of the issuer's common stock to a national securities exchange"
A national securities exchange is a regulated marketplace where buyers and sellers trade stocks, bonds and other securities and where companies meet requirements to have their shares available to the public. It matters to investors because the exchange enforces rules, provides transparent prices and a steady flow of buyers and sellers—like a supervised marketplace that helps ensure fair pricing, easier buying and selling, and basic investor protections.
time-based vesting financial
"RSUs, subject to performance and time-based vesting"
Time-based vesting is a schedule that gives employees or contractors ownership of granted stock or options gradually as they remain with a company, like unlocking rewards in a loyalty program the longer you stick around. For investors, it matters because it affects future share supply, management incentives and staff retention — all of which can influence company performance and dilution of existing shareholders.
FAQ
What equity award did Oncotelic Therapeutics (OTLC) grant to CFO Amit B. Shah?
Oncotelic Therapeutics granted CFO Amit B. Shah 1,500 restricted stock units (RSUs) on July 10, 2026. These RSUs are a compensation award and involve no cash purchase, with settlement into Series A Convertible Preferred Stock if vesting conditions are achieved.
What are the vesting conditions for the OTLC CFO’s 1,500 RSUs?
The 1,500 RSUs vest only upon achieving an uplisting to a national securities exchange on or before June 30, 2027, or a later board-approved date. Vesting also requires Amit B. Shah’s continued service for six months following that uplisting.
How will the OTLC CFO’s RSUs be settled once they vest?
Upon vesting, each RSU will be settled by delivering one share of Series A Convertible Preferred Stock. Each such preferred share is, in turn, convertible into shares of Oncotelic’s common stock, giving the award potential exposure to the company’s common equity if all conversions occur.
Does the OTLC CFO’s RSU grant involve any immediate cash transaction?
No. The RSU grant to the OTLC CFO carries a transaction price of $0.0000 per unit, reflecting a compensation-based award rather than an open-market purchase or sale. Economic value depends on future vesting, preferred share issuance, and possible conversion into common stock.
What ongoing service requirement applies to the OTLC CFO’s RSU award?
For the 1,500 RSUs to vest, Amit B. Shah must remain in service for six months after the uplisting to a national securities exchange. Both the uplisting event and this continued service condition must be satisfied for the award to deliver Series A Convertible Preferred Stock.